Today, a dispatch on what can go wrong when machine learning hype outpaces reality: a high-profile partnership between IBM Watson and MD Anderson Cancer Center has recently hit the rocks as it turns out to be tougher than expected to cure cancer with artificial intelligence. There are enough conflicting accounts in the media to make it tough to say exactly went wrong, but it's a good chance to remind ourselves that even in a post-AI world, hard problems remain hard.
